

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 9.59376195 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 9.59376195 |
| 3 | regulation of phospholipase A2 activity (GO:0032429) | 7.13585217 |
| 4 | regulation of cholesterol esterification (GO:0010872) | 6.82802267 |
| 5 | endocrine pancreas development (GO:0031018) | 6.30720163 |
| 6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.29691479 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.22683503 |
| 8 | peptide hormone processing (GO:0016486) | 6.03619635 |
| 9 | dorsal/ventral axis specification (GO:0009950) | 5.71762470 |
| 10 | type B pancreatic cell development (GO:0003323) | 5.68278005 |
| 11 | glandular epithelial cell differentiation (GO:0002067) | 5.59379876 |
| 12 | protein retention in ER lumen (GO:0006621) | 5.57354068 |
| 13 | low-density lipoprotein particle remodeling (GO:0034374) | 5.54056004 |
| 14 | glandular epithelial cell development (GO:0002068) | 5.16556709 |
| 15 | regulation of acrosome reaction (GO:0060046) | 5.09895082 |
| 16 | COPII vesicle coating (GO:0048208) | 4.99080007 |
| 17 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.92947541 |
| 18 | insulin secretion (GO:0030073) | 4.90646383 |
| 19 | positive regulation of insulin secretion (GO:0032024) | 4.74589003 |
| 20 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.70505781 |
| 21 | virion attachment to host cell (GO:0019062) | 4.67046949 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 4.67046949 |
| 23 | brain morphogenesis (GO:0048854) | 4.62524860 |
| 24 | epithelial cell fate commitment (GO:0072148) | 4.54364370 |
| 25 | cellular response to vitamin D (GO:0071305) | 4.53792434 |
| 26 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.51452176 |
| 27 | polarized epithelial cell differentiation (GO:0030859) | 4.51290807 |
| 28 | signal peptide processing (GO:0006465) | 4.48623715 |
| 29 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.47240665 |
| 30 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.44357862 |
| 31 | glycerophospholipid catabolic process (GO:0046475) | 4.42211815 |
| 32 | vesicle coating (GO:0006901) | 4.39146130 |
| 33 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.36461329 |
| 34 | protein maturation by protein folding (GO:0022417) | 4.35476401 |
| 35 | ncRNA 3-end processing (GO:0043628) | 4.30828564 |
| 36 | inner ear receptor cell differentiation (GO:0060113) | 4.29949253 |
| 37 | nucleotide transmembrane transport (GO:1901679) | 4.28986525 |
| 38 | serotonin metabolic process (GO:0042428) | 4.25220874 |
| 39 | positive regulation of nuclease activity (GO:0032075) | 4.21770896 |
| 40 | indolalkylamine metabolic process (GO:0006586) | 4.19623640 |
| 41 | fucose catabolic process (GO:0019317) | 4.12116010 |
| 42 | L-fucose metabolic process (GO:0042354) | 4.12116010 |
| 43 | L-fucose catabolic process (GO:0042355) | 4.12116010 |
| 44 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.05668506 |
| 45 | xenobiotic catabolic process (GO:0042178) | 4.03275512 |
| 46 | exocrine pancreas development (GO:0031017) | 4.01928038 |
| 47 | regulation of insulin secretion (GO:0050796) | 4.01363362 |
| 48 | transcytosis (GO:0045056) | 4.01197812 |
| 49 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.00639756 |
| 50 | positive regulation of steroid metabolic process (GO:0045940) | 3.99060759 |
| 51 | auditory receptor cell differentiation (GO:0042491) | 3.92207552 |
| 52 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.86851012 |
| 53 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.86851012 |
| 54 | endocrine process (GO:0050886) | 3.86851012 |
| 55 | nonmotile primary cilium assembly (GO:0035058) | 3.86400013 |
| 56 | toxin metabolic process (GO:0009404) | 3.86078301 |
| 57 | regulation of Rac protein signal transduction (GO:0035020) | 3.83632596 |
| 58 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.82724461 |
| 59 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.82432133 |
| 60 | macroautophagy (GO:0016236) | 3.82250816 |
| 61 | positive regulation of peptide hormone secretion (GO:0090277) | 3.81885745 |
| 62 | regulation of nuclease activity (GO:0032069) | 3.81556184 |
| 63 | primary amino compound metabolic process (GO:1901160) | 3.78673937 |
| 64 | potassium ion import (GO:0010107) | 3.76899456 |
| 65 | nitric oxide mediated signal transduction (GO:0007263) | 3.76076568 |
| 66 | regulation of autophagic vacuole assembly (GO:2000785) | 3.75413764 |
| 67 | detection of calcium ion (GO:0005513) | 3.74709343 |
| 68 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.72453073 |
| 69 | inositol phosphate dephosphorylation (GO:0046855) | 3.72453073 |
| 70 | RNA destabilization (GO:0050779) | 3.70794290 |
| 71 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.70592911 |
| 72 | adhesion of symbiont to host (GO:0044406) | 3.70021851 |
| 73 | positive regulation of peptide secretion (GO:0002793) | 3.69602578 |
| 74 | peptide hormone secretion (GO:0030072) | 3.68813769 |
| 75 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.65500068 |
| 76 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.64832511 |
| 77 | phenylpropanoid metabolic process (GO:0009698) | 3.63500898 |
| 78 | inositol phosphate catabolic process (GO:0071545) | 3.62812784 |
| 79 | negative regulation of JUN kinase activity (GO:0043508) | 3.62476813 |
| 80 | regulation of peptide hormone secretion (GO:0090276) | 3.61460701 |
| 81 | peptide secretion (GO:0002790) | 3.60161522 |
| 82 | ER-nucleus signaling pathway (GO:0006984) | 3.59275894 |
| 83 | cellular response to unfolded protein (GO:0034620) | 3.57538462 |
| 84 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.56824999 |
| 85 | response to hepatocyte growth factor (GO:0035728) | 3.56824999 |
| 86 | regulation of peptide secretion (GO:0002791) | 3.55039679 |
| 87 | thalamus development (GO:0021794) | 3.54568125 |
| 88 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.53856484 |
| 89 | axoneme assembly (GO:0035082) | 3.53513472 |
| 90 | protein autoprocessing (GO:0016540) | 3.51093475 |
| 91 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.50279031 |
| 92 | cellular response to topologically incorrect protein (GO:0035967) | 3.44017685 |
| 93 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.43582349 |
| 94 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.43400844 |
| 95 | sequestering of metal ion (GO:0051238) | 3.42113482 |
| 96 | establishment of apical/basal cell polarity (GO:0035089) | 3.39091974 |
| 97 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.36057591 |
| 98 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.35000273 |
| 99 | cerebellar Purkinje cell layer development (GO:0021680) | 3.34824088 |
| 100 | positive regulation of calcium ion import (GO:0090280) | 3.33781345 |
| 101 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.32510536 |
| 102 | DNA damage induced protein phosphorylation (GO:0006975) | 3.32168169 |
| 103 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 3.30989010 |
| 104 | ER overload response (GO:0006983) | 3.30553892 |
| 105 | astrocyte differentiation (GO:0048708) | 3.29660116 |
| 106 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.27783971 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27385991 |
| 108 | protein-lipid complex remodeling (GO:0034368) | 3.27385991 |
| 109 | macromolecular complex remodeling (GO:0034367) | 3.27385991 |
| 110 | regulation of sequestering of triglyceride (GO:0010889) | 3.25281345 |
| 111 | cellular response to glucagon stimulus (GO:0071377) | 3.24283007 |
| 112 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.21089667 |
| 113 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.20726258 |
| 114 | reflex (GO:0060004) | 3.19693972 |
| 115 | monoamine transport (GO:0015844) | 3.18743907 |
| 116 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.17310464 |
| 117 | protein targeting to Golgi (GO:0000042) | 3.16081494 |
| 118 | regulation of response to food (GO:0032095) | 3.15365290 |
| 119 | drinking behavior (GO:0042756) | 3.15352822 |
| 120 | intestinal cholesterol absorption (GO:0030299) | 3.13833222 |
| 121 | chemosensory behavior (GO:0007635) | 3.13045503 |
| 122 | mRNA modification (GO:0016556) | 3.13032225 |
| 123 | potassium ion export (GO:0071435) | 3.12732061 |
| 124 | positive regulation of vesicle fusion (GO:0031340) | 3.11557194 |
| 125 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.11487747 |
| 126 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.10971122 |
| 127 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.09495037 |
| 128 | regulation of hormone secretion (GO:0046883) | 3.09096243 |
| 129 | cellular response to vitamin (GO:0071295) | 3.07634299 |
| 130 | regulation of vacuole organization (GO:0044088) | 3.06590193 |
| 131 | polyol catabolic process (GO:0046174) | 3.05485027 |
| 132 | response to endoplasmic reticulum stress (GO:0034976) | 3.03570374 |
| 133 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.02849182 |
| 134 | protein localization to Golgi apparatus (GO:0034067) | 3.02449474 |
| 135 | membrane repolarization during action potential (GO:0086011) | 3.02395468 |
| 136 | indole-containing compound metabolic process (GO:0042430) | 3.02185611 |
| 137 | L-phenylalanine catabolic process (GO:0006559) | 3.01316593 |
| 138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.01316593 |
| 139 | regulation of systemic arterial blood pressure (GO:0003073) | 3.00428834 |
| 140 | benzene-containing compound metabolic process (GO:0042537) | 3.00086732 |
| 141 | response to ischemia (GO:0002931) | 2.99943492 |
| 142 | pancreas development (GO:0031016) | 2.97407562 |
| 143 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.97050446 |
| 144 | positive regulation of hormone secretion (GO:0046887) | 2.96659063 |
| 145 | establishment of monopolar cell polarity (GO:0061162) | 2.95240659 |
| 146 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.95240659 |
| 147 | regulation of protein glycosylation (GO:0060049) | 2.94032645 |
| 148 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.93960690 |
| 149 | negative regulation of response to food (GO:0032096) | 2.92829164 |
| 150 | negative regulation of appetite (GO:0032099) | 2.92829164 |
| 151 | hormone secretion (GO:0046879) | 2.92289800 |
| 152 | negative regulation of digestive system process (GO:0060457) | 2.91770894 |
| 153 | response to dietary excess (GO:0002021) | 2.91741201 |
| 154 | regulation of peptide transport (GO:0090087) | 2.91515318 |
| 155 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.89601234 |
| 156 | regulation of glucocorticoid secretion (GO:2000849) | 2.88754801 |
| 157 | cellular ketone body metabolic process (GO:0046950) | 2.88230489 |
| 158 | cornea development in camera-type eye (GO:0061303) | 2.86772625 |
| 159 | nephron epithelium morphogenesis (GO:0072088) | 2.86396971 |
| 160 | nephron tubule morphogenesis (GO:0072078) | 2.86396971 |
| 161 | mechanosensory behavior (GO:0007638) | 2.85960148 |
| 162 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.84791345 |
| 163 | muscle hypertrophy in response to stress (GO:0003299) | 2.84791345 |
| 164 | cardiac muscle adaptation (GO:0014887) | 2.84791345 |
| 165 | early endosome to late endosome transport (GO:0045022) | 2.81464316 |
| 166 | positive regulation of neurological system process (GO:0031646) | 2.75905576 |
| 167 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.75310879 |
| 168 | aromatic amino acid family catabolic process (GO:0009074) | 2.72760163 |
| 169 | epithelial cilium movement (GO:0003351) | 2.71179888 |
| 170 | artery smooth muscle contraction (GO:0014824) | 2.69150001 |
| 171 | mechanoreceptor differentiation (GO:0042490) | 2.68675243 |
| 172 | eosinophil chemotaxis (GO:0048245) | 2.68414853 |
| 173 | regulation of vasoconstriction (GO:0019229) | 2.68389189 |
| 174 | dentate gyrus development (GO:0021542) | 2.67866905 |
| 175 | cardiac conduction (GO:0061337) | 2.67626811 |
| 176 | cellular response to gonadotropin stimulus (GO:0071371) | 2.67321010 |
| 177 | response to pheromone (GO:0019236) | 2.66572720 |
| 178 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.62258865 |
| 179 | dopamine transport (GO:0015872) | 2.61437558 |
| 180 | L-phenylalanine metabolic process (GO:0006558) | 2.60507725 |
| 181 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.60507725 |
| 182 | aromatic amino acid family metabolic process (GO:0009072) | 2.59585947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.89162525 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.17047571 |
| 3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.82363872 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.55175981 |
| 5 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.46133231 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43125257 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.38893172 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30680049 |
| 9 | FUS_26573619_Chip-Seq_HEK293_Human | 2.19146092 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16986016 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16754463 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11482212 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03603527 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.02647685 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 12.4864071 |
| 16 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.82495891 |
| 17 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77421784 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76561826 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75286373 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.70322499 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68988350 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65719803 |
| 23 | AR_25329375_ChIP-Seq_VCAP_Human | 1.65302814 |
| 24 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.65222437 |
| 25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.64399707 |
| 26 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.62797199 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60502686 |
| 28 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.59059825 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57601543 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54705007 |
| 31 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52877505 |
| 32 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52599926 |
| 33 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.52371213 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50560541 |
| 35 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49014866 |
| 36 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.47542954 |
| 37 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46288381 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.44802059 |
| 39 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44316087 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44131369 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43109955 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41470990 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40331811 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40190298 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39283431 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38341835 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37896059 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35835090 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32953888 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31450236 |
| 51 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29908687 |
| 52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29691083 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29197438 |
| 54 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.28623922 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27702250 |
| 56 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.27267877 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27255091 |
| 58 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27051361 |
| 59 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26078325 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22531005 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21574933 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20764482 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20604664 |
| 64 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20329677 |
| 65 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19892623 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19609385 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19311959 |
| 68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18544286 |
| 69 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17152912 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.15613183 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15328139 |
| 72 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14883772 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14847100 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14208494 |
| 75 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14133222 |
| 76 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14133222 |
| 77 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13867664 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13431557 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11649617 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11625727 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11590496 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10896559 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10425585 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10393322 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09823835 |
| 86 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09016112 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08672053 |
| 88 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08385135 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07263233 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06804115 |
| 91 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04566952 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04511756 |
| 93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04448616 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03739690 |
| 95 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03392954 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03211280 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03044663 |
| 98 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02843142 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01593080 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01155264 |
| 101 | TBL1_22424771_ChIP-Seq_293T_Human | 1.00958206 |
| 102 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00683236 |
| 103 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00460073 |
| 104 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00224214 |
| 105 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00224214 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99502884 |
| 107 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99156554 |
| 108 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98451107 |
| 109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98304013 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98174105 |
| 111 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97889585 |
| 112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97415298 |
| 113 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97017510 |
| 114 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96917094 |
| 115 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96289704 |
| 116 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96283918 |
| 117 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95881520 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95107180 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94786031 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94786031 |
| 121 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94596223 |
| 122 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94509098 |
| 123 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93854612 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93666715 |
| 125 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92446517 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92424892 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92273550 |
| 128 | AR_19668381_ChIP-Seq_PC3_Human | 0.91755831 |
| 129 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91693566 |
| 130 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.91333139 |
| 131 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90971345 |
| 132 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90067395 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89691392 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89082952 |
| 135 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88775041 |
| 136 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87911696 |
| 137 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87721222 |
| 138 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.85819887 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85524058 |
| 140 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.84631639 |
| 141 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84273705 |
| 142 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82623754 |
| 143 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80360607 |
| 144 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80360607 |
| 145 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.80147759 |
| 146 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.80049049 |
| 147 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.78282327 |
| 148 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77753636 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77663865 |
| 150 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77229449 |
| 151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75326063 |
| 152 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73800961 |
| 153 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73301729 |
| 154 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72737047 |
| 155 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.72556754 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72000412 |
| 157 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.71750195 |
| 158 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.71693689 |
| 159 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70806088 |
| 160 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.70789976 |
| 161 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69655758 |
| 162 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.69308676 |
| 163 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.68490545 |
| 164 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.67901369 |
| 165 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.67879441 |
| 166 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.67872184 |
| 167 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.67838474 |
| 168 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.67323595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 6.36305536 |
| 2 | MP0003183_abnormal_peptide_metabolism | 5.27358205 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 4.67091429 |
| 4 | MP0003195_calcinosis | 4.54361136 |
| 5 | MP0002909_abnormal_adrenal_gland | 4.08906578 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 3.56097573 |
| 7 | MP0003283_abnormal_digestive_organ | 3.52603933 |
| 8 | MP0001944_abnormal_pancreas_morphology | 3.52422596 |
| 9 | MP0002693_abnormal_pancreas_physiology | 3.43637675 |
| 10 | MP0010386_abnormal_urinary_bladder | 3.33060926 |
| 11 | MP0005379_endocrine/exocrine_gland_phen | 3.31313503 |
| 12 | MP0000003_abnormal_adipose_tissue | 3.27476647 |
| 13 | MP0001501_abnormal_sleep_pattern | 3.27170304 |
| 14 | MP0004043_abnormal_pH_regulation | 3.27077363 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 3.18974578 |
| 16 | MP0000678_abnormal_parathyroid_gland | 2.98184880 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.63531953 |
| 18 | MP0005220_abnormal_exocrine_pancreas | 2.57887528 |
| 19 | MP0005310_abnormal_salivary_gland | 2.46179054 |
| 20 | MP0009046_muscle_twitch | 2.45356957 |
| 21 | MP0003646_muscle_fatigue | 2.34008264 |
| 22 | MP0001984_abnormal_olfaction | 2.31849790 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.25239417 |
| 24 | MP0004270_analgesia | 2.21647782 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.20582822 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.10744319 |
| 27 | MP0002078_abnormal_glucose_homeostasis | 2.08662433 |
| 28 | MP0000383_abnormal_hair_follicle | 2.07029126 |
| 29 | MP0002254_reproductive_system_inflammat | 2.03761999 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 2.02540751 |
| 31 | MP0001502_abnormal_circadian_rhythm | 1.97957762 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.91399149 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.87009969 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.79312188 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.77201830 |
| 36 | MP0003122_maternal_imprinting | 1.73847111 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.69725994 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.67953185 |
| 39 | MP0001765_abnormal_ion_homeostasis | 1.63789516 |
| 40 | MP0001764_abnormal_homeostasis | 1.61498383 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.61357010 |
| 42 | MP0002896_abnormal_bone_mineralization | 1.60620511 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.56557452 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.54448605 |
| 45 | MP0003959_abnormal_lean_body | 1.50869465 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.49168596 |
| 47 | MP0003941_abnormal_skin_development | 1.45612708 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.45246655 |
| 49 | MP0005365_abnormal_bile_salt | 1.44925727 |
| 50 | MP0003011_delayed_dark_adaptation | 1.42220532 |
| 51 | MP0002272_abnormal_nervous_system | 1.38334651 |
| 52 | MP0008057_abnormal_DNA_replication | 1.34986625 |
| 53 | MP0005360_urolithiasis | 1.33748007 |
| 54 | MP0001661_extended_life_span | 1.31367428 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.30623921 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.29840824 |
| 57 | MP0001756_abnormal_urination | 1.28056531 |
| 58 | MP0003787_abnormal_imprinting | 1.26538068 |
| 59 | MP0003252_abnormal_bile_duct | 1.26308778 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.25522943 |
| 61 | MP0003953_abnormal_hormone_level | 1.23994361 |
| 62 | MP0000613_abnormal_salivary_gland | 1.21539734 |
| 63 | MP0004885_abnormal_endolymph | 1.20888225 |
| 64 | MP0003868_abnormal_feces_composition | 1.20148045 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.17396405 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.17134952 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.14822070 |
| 68 | MP0005595_abnormal_vascular_smooth | 1.13852591 |
| 69 | MP0005332_abnormal_amino_acid | 1.13362100 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.12873932 |
| 71 | MP0003123_paternal_imprinting | 1.08999033 |
| 72 | MP0003786_premature_aging | 1.07376240 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 1.04988514 |
| 74 | MP0001958_emphysema | 1.04190764 |
| 75 | MP0002163_abnormal_gland_morphology | 1.03566610 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.01660303 |
| 77 | MP0002971_abnormal_brown_adipose | 1.01392086 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 1.00624963 |
| 79 | MP0002928_abnormal_bile_duct | 1.00418942 |
| 80 | MP0004133_heterotaxia | 0.99841549 |
| 81 | MP0003045_fibrosis | 0.99702956 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 0.98871887 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.98526169 |
| 84 | MP0009745_abnormal_behavioral_response | 0.98482328 |
| 85 | MP0003879_abnormal_hair_cell | 0.97955713 |
| 86 | MP0000372_irregular_coat_pigmentation | 0.96808191 |
| 87 | MP0003119_abnormal_digestive_system | 0.94977255 |
| 88 | MP0000427_abnormal_hair_cycle | 0.94288340 |
| 89 | MP0005620_abnormal_muscle_contractility | 0.93563381 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.92720418 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.91408333 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.89584251 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.88549650 |
| 94 | MP0001919_abnormal_reproductive_system | 0.86751850 |
| 95 | MP0002938_white_spotting | 0.86128265 |
| 96 | MP0006054_spinal_hemorrhage | 0.85316504 |
| 97 | MP0003121_genomic_imprinting | 0.83302567 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.82826286 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.82764180 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.78542247 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.78267390 |
| 102 | MP0001270_distended_abdomen | 0.78132638 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 0.78096598 |
| 104 | MP0001666_abnormal_nutrient_absorption | 0.77909095 |
| 105 | MP0002064_seizures | 0.77834245 |
| 106 | MP0001968_abnormal_touch/_nociception | 0.75548164 |
| 107 | MP0006082_CNS_inflammation | 0.74482219 |
| 108 | MP0005535_abnormal_body_temperature | 0.72590706 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72303312 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.71434617 |
| 111 | MP0005389_reproductive_system_phenotype | 0.71124424 |
| 112 | MP0005330_cardiomyopathy | 0.70995148 |
| 113 | MP0002229_neurodegeneration | 0.69521037 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.69109451 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.67336762 |
| 116 | MP0004924_abnormal_behavior | 0.67051668 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.67051668 |
| 118 | MP0003186_abnormal_redox_activity | 0.66601981 |
| 119 | MP0005257_abnormal_intraocular_pressure | 0.65986995 |
| 120 | MP0000462_abnormal_digestive_system | 0.65759317 |
| 121 | MP0005334_abnormal_fat_pad | 0.64369123 |
| 122 | MP0002168_other_aberrant_phenotype | 0.61462097 |
| 123 | MP0001188_hyperpigmentation | 0.61229441 |
| 124 | MP0002751_abnormal_autonomic_nervous | 0.59105904 |
| 125 | MP0001664_abnormal_digestion | 0.59017095 |
| 126 | MP0005408_hypopigmentation | 0.57794118 |
| 127 | MP0005448_abnormal_energy_balance | 0.57604023 |
| 128 | MP0005670_abnormal_white_adipose | 0.57526890 |
| 129 | MP0002177_abnormal_outer_ear | 0.57051121 |
| 130 | MP0004085_abnormal_heartbeat | 0.56402218 |
| 131 | MP0000428_abnormal_craniofacial_morphol | 0.55621222 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.55111734 |
| 133 | MP0002733_abnormal_thermal_nociception | 0.54892421 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.53760085 |
| 135 | MP0000681_abnormal_thyroid_gland | 0.51472451 |
| 136 | MP0000955_abnormal_spinal_cord | 0.49793382 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.49510676 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.49272490 |
| 139 | MP0005253_abnormal_eye_physiology | 0.47624910 |
| 140 | MP0005452_abnormal_adipose_tissue | 0.47620613 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.47440687 |
| 142 | MP0003633_abnormal_nervous_system | 0.46209417 |
| 143 | MP0009672_abnormal_birth_weight | 0.45417225 |
| 144 | MP0002009_preneoplasia | 0.45384988 |
| 145 | MP0003638_abnormal_response/metabolism_ | 0.45155474 |
| 146 | MP0004130_abnormal_muscle_cell | 0.43905289 |
| 147 | MP0001970_abnormal_pain_threshold | 0.42583538 |
| 148 | MP0000470_abnormal_stomach_morphology | 0.41996839 |
| 149 | MP0004036_abnormal_muscle_relaxation | 0.41896298 |
| 150 | MP0005248_abnormal_Harderian_gland | 0.41454908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.90393178 |
| 2 | Potter facies (HP:0002009) | 7.85880136 |
| 3 | Facial shape deformation (HP:0011334) | 7.85880136 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.75895450 |
| 5 | Hypoglycemic seizures (HP:0002173) | 7.01442231 |
| 6 | Symptomatic seizures (HP:0011145) | 6.09744303 |
| 7 | Hyperglycemia (HP:0003074) | 5.78313334 |
| 8 | Hypoglycemic coma (HP:0001325) | 5.54881562 |
| 9 | Vascular calcification (HP:0004934) | 5.42849306 |
| 10 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.37397164 |
| 11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.33067061 |
| 12 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.03738077 |
| 13 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.95812008 |
| 14 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.95812008 |
| 15 | Large for gestational age (HP:0001520) | 4.85408558 |
| 16 | Cardiovascular calcification (HP:0011915) | 4.79588477 |
| 17 | Ketoacidosis (HP:0001993) | 4.48325562 |
| 18 | Late onset (HP:0003584) | 4.34057579 |
| 19 | Progressive sensorineural hearing impairment (HP:0000408) | 4.03483908 |
| 20 | Widely patent fontanelles and sutures (HP:0004492) | 3.90552750 |
| 21 | Decreased circulating renin level (HP:0003351) | 3.88265095 |
| 22 | Abnormality of renal excretion (HP:0011036) | 3.79617349 |
| 23 | Prominent supraorbital ridges (HP:0000336) | 3.73016399 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.63658122 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.63658122 |
| 26 | Hyperparathyroidism (HP:0000843) | 3.62044654 |
| 27 | Prominent metopic ridge (HP:0005487) | 3.61768611 |
| 28 | Mitral stenosis (HP:0001718) | 3.52072920 |
| 29 | Agitation (HP:0000713) | 3.51778096 |
| 30 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.46237682 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.33659821 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33659821 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33659821 |
| 34 | Hypokalemia (HP:0002900) | 3.29639519 |
| 35 | Septate vagina (HP:0001153) | 3.23915486 |
| 36 | Urethral obstruction (HP:0000796) | 3.16402215 |
| 37 | Type II lissencephaly (HP:0007260) | 3.11191955 |
| 38 | Abnormality of the metopic suture (HP:0005556) | 3.10046556 |
| 39 | Hyperventilation (HP:0002883) | 3.09968606 |
| 40 | Increased circulating renin level (HP:0000848) | 3.04123417 |
| 41 | Hyperkalemia (HP:0002153) | 3.03550599 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 3.02759619 |
| 43 | Skin nodule (HP:0200036) | 3.02603581 |
| 44 | Progressive hearing impairment (HP:0001730) | 2.98596302 |
| 45 | Insulin resistance (HP:0000855) | 2.97870097 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.97729202 |
| 47 | Abnormal urine output (HP:0012590) | 2.96416508 |
| 48 | Abnormal biliary tract physiology (HP:0012439) | 2.94097764 |
| 49 | Bile duct proliferation (HP:0001408) | 2.94097764 |
| 50 | Retinal atrophy (HP:0001105) | 2.93148963 |
| 51 | Abnormality of potassium homeostasis (HP:0011042) | 2.92649831 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.91764297 |
| 53 | Hydroureter (HP:0000072) | 2.90781671 |
| 54 | Osteomalacia (HP:0002749) | 2.87738286 |
| 55 | Hyperphosphatemia (HP:0002905) | 2.87139080 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.84226396 |
| 57 | Abnormal pancreas size (HP:0012094) | 2.83764054 |
| 58 | Unilateral renal agenesis (HP:0000122) | 2.82007761 |
| 59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.77568947 |
| 60 | Pancreatic cysts (HP:0001737) | 2.75478592 |
| 61 | Methylmalonic acidemia (HP:0002912) | 2.71518818 |
| 62 | Volvulus (HP:0002580) | 2.70152976 |
| 63 | Papilledema (HP:0001085) | 2.66719582 |
| 64 | Short hallux (HP:0010109) | 2.65120976 |
| 65 | Pancreatic fibrosis (HP:0100732) | 2.64527486 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.61871303 |
| 67 | Limb dystonia (HP:0002451) | 2.61577895 |
| 68 | Stomatitis (HP:0010280) | 2.61449562 |
| 69 | Arthropathy (HP:0003040) | 2.61076693 |
| 70 | Hypsarrhythmia (HP:0002521) | 2.61046050 |
| 71 | Attenuation of retinal blood vessels (HP:0007843) | 2.51744581 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.50502978 |
| 73 | Abnormality of vitamin B metabolism (HP:0004340) | 2.48901002 |
| 74 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.41392910 |
| 75 | Ketosis (HP:0001946) | 2.41070098 |
| 76 | Tachypnea (HP:0002789) | 2.41002371 |
| 77 | Bifid tongue (HP:0010297) | 2.40787510 |
| 78 | Cerebellar dysplasia (HP:0007033) | 2.40674280 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.40654848 |
| 80 | Glycosuria (HP:0003076) | 2.40654848 |
| 81 | Abnormality of renal resorption (HP:0011038) | 2.35871415 |
| 82 | Thickened helices (HP:0000391) | 2.34093166 |
| 83 | Hyperactive renin-angiotensin system (HP:0000841) | 2.32730782 |
| 84 | Cystic liver disease (HP:0006706) | 2.32418247 |
| 85 | Hypotension (HP:0002615) | 2.29938417 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.26357392 |
| 87 | Enlarged penis (HP:0000040) | 2.26203503 |
| 88 | True hermaphroditism (HP:0010459) | 2.25819289 |
| 89 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.24380980 |
| 90 | Hypercortisolism (HP:0001578) | 2.23062226 |
| 91 | Hypophosphatemia (HP:0002148) | 2.22575072 |
| 92 | Restlessness (HP:0000711) | 2.22323143 |
| 93 | Cervical subluxation (HP:0003308) | 2.21289496 |
| 94 | Hyperphosphaturia (HP:0003109) | 2.20737878 |
| 95 | Prolonged QT interval (HP:0001657) | 2.20490583 |
| 96 | Generalized hyperpigmentation (HP:0007440) | 2.20101469 |
| 97 | Congenital primary aphakia (HP:0007707) | 2.18714305 |
| 98 | Macroorchidism (HP:0000053) | 2.18332053 |
| 99 | Chronic bronchitis (HP:0004469) | 2.17649933 |
| 100 | Furrowed tongue (HP:0000221) | 2.16152325 |
| 101 | Gait imbalance (HP:0002141) | 2.14382464 |
| 102 | Methylmalonic aciduria (HP:0012120) | 2.14216359 |
| 103 | Steatorrhea (HP:0002570) | 2.13431417 |
| 104 | Menstrual irregularities (HP:0000858) | 2.08051123 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07762652 |
| 106 | J-shaped sella turcica (HP:0002680) | 2.02680318 |
| 107 | Homocystinuria (HP:0002156) | 2.01342331 |
| 108 | Abnormality of homocysteine metabolism (HP:0010919) | 2.01342331 |
| 109 | Abnormal drinking behavior (HP:0030082) | 2.01315185 |
| 110 | Polydipsia (HP:0001959) | 2.01315185 |
| 111 | Progressive neurologic deterioration (HP:0002344) | 1.98960551 |
| 112 | Congenital glaucoma (HP:0001087) | 1.98853829 |
| 113 | Submucous cleft hard palate (HP:0000176) | 1.98266422 |
| 114 | Redundant skin (HP:0001582) | 1.97597544 |
| 115 | Adrenal overactivity (HP:0002717) | 1.96633124 |
| 116 | Barrel-shaped chest (HP:0001552) | 1.95369329 |
| 117 | Megaloblastic anemia (HP:0001889) | 1.95135735 |
| 118 | Disproportionate short-trunk short stature (HP:0003521) | 1.93734424 |
| 119 | Dysautonomia (HP:0002459) | 1.93264694 |
| 120 | Truncal obesity (HP:0001956) | 1.92816846 |
| 121 | Missing ribs (HP:0000921) | 1.92156396 |
| 122 | Hypoplastic labia majora (HP:0000059) | 1.91455143 |
| 123 | Abnormality of chloride homeostasis (HP:0011422) | 1.90424593 |
| 124 | Global brain atrophy (HP:0002283) | 1.89997860 |
| 125 | Abdominal distention (HP:0003270) | 1.89039200 |
| 126 | Tubular atrophy (HP:0000092) | 1.88918788 |
| 127 | Severe visual impairment (HP:0001141) | 1.87152358 |
| 128 | Wide cranial sutures (HP:0010537) | 1.84849847 |
| 129 | Limb hypertonia (HP:0002509) | 1.84427698 |
| 130 | Nephronophthisis (HP:0000090) | 1.83421561 |
| 131 | Abolished electroretinogram (ERG) (HP:0000550) | 1.83406821 |
| 132 | Abnormal urine phosphate concentration (HP:0012599) | 1.83223748 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.80662294 |
| 134 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.77833601 |
| 135 | Oligohydramnios (HP:0001562) | 1.77226496 |
| 136 | Occipital encephalocele (HP:0002085) | 1.75539225 |
| 137 | Cardiomegaly (HP:0001640) | 1.74003722 |
| 138 | Abnormality of magnesium homeostasis (HP:0004921) | 1.73277133 |
| 139 | Impaired smooth pursuit (HP:0007772) | 1.72818329 |
| 140 | Round ear (HP:0100830) | 1.72316345 |
| 141 | Hypothermia (HP:0002045) | 1.72287672 |
| 142 | Exocrine pancreatic insufficiency (HP:0001738) | 1.72209372 |
| 143 | Spinal muscular atrophy (HP:0007269) | 1.71125157 |
| 144 | Zonular cataract (HP:0010920) | 1.70959114 |
| 145 | Hyperaldosteronism (HP:0000859) | 1.70204022 |
| 146 | Gaze-evoked nystagmus (HP:0000640) | 1.69790468 |
| 147 | Constricted visual fields (HP:0001133) | 1.69770042 |
| 148 | Tetany (HP:0001281) | 1.68857823 |
| 149 | Abnormality of the labia majora (HP:0012881) | 1.68705755 |
| 150 | Broad-based gait (HP:0002136) | 1.67566399 |
| 151 | Absent eyebrow (HP:0002223) | 1.66790495 |
| 152 | Hyponatremia (HP:0002902) | 1.66542218 |
| 153 | Severe muscular hypotonia (HP:0006829) | 1.65705683 |
| 154 | Muscular hypotonia of the trunk (HP:0008936) | 1.65517294 |
| 155 | Abnormality of permanent molar morphology (HP:0011071) | 1.64511232 |
| 156 | Abnormality of the dental root (HP:0006486) | 1.64511232 |
| 157 | Taurodontia (HP:0000679) | 1.64511232 |
| 158 | Hemiparesis (HP:0001269) | 1.63042424 |
| 159 | Growth hormone excess (HP:0000845) | 1.62071970 |
| 160 | Congenital sensorineural hearing impairment (HP:0008527) | 1.61971673 |
| 161 | Pheochromocytoma (HP:0002666) | 1.61682289 |
| 162 | Enlarged kidneys (HP:0000105) | 1.61212601 |
| 163 | Blue irides (HP:0000635) | 1.60788548 |
| 164 | Hypomagnesemia (HP:0002917) | 1.60569066 |
| 165 | Protuberant abdomen (HP:0001538) | 1.59889528 |
| 166 | Hypocalcemia (HP:0002901) | 1.59084745 |
| 167 | Ulnar deviation of the wrist (HP:0003049) | 1.59045943 |
| 168 | Increased CSF protein (HP:0002922) | 1.56413870 |
| 169 | Orthostatic hypotension (HP:0001278) | 1.55339295 |
| 170 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.55306170 |
| 171 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.54704422 |
| 172 | Hypoplasia of the fovea (HP:0007750) | 1.54704422 |
| 173 | Abnormality of the common coagulation pathway (HP:0010990) | 1.53922936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 5.49154882 |
| 2 | INSRR | 4.89480287 |
| 3 | ACVR1B | 4.69198493 |
| 4 | IRAK4 | 4.21756342 |
| 5 | FRK | 4.07071241 |
| 6 | TAOK3 | 4.05046335 |
| 7 | MAP3K6 | 3.42562152 |
| 8 | PIK3CG | 3.30239853 |
| 9 | MAPK15 | 3.28285186 |
| 10 | PASK | 3.26318260 |
| 11 | MAP4K2 | 3.26169992 |
| 12 | PRKD3 | 3.23691119 |
| 13 | MAP3K2 | 3.16848575 |
| 14 | MAP3K4 | 3.02082269 |
| 15 | IRAK3 | 3.00195041 |
| 16 | UHMK1 | 2.80391064 |
| 17 | HIPK2 | 2.78344732 |
| 18 | MAP2K7 | 2.76272944 |
| 19 | WNK4 | 2.32116025 |
| 20 | STK24 | 2.20194806 |
| 21 | FGFR2 | 2.05348727 |
| 22 | MST4 | 1.94582648 |
| 23 | CAMKK2 | 1.90349946 |
| 24 | MAP3K1 | 1.89611331 |
| 25 | MAP2K4 | 1.81781809 |
| 26 | MAP3K5 | 1.75671247 |
| 27 | TRIB3 | 1.73295812 |
| 28 | PNCK | 1.62278358 |
| 29 | MAP2K6 | 1.61955907 |
| 30 | ERN1 | 1.52441496 |
| 31 | EPHA3 | 1.51960812 |
| 32 | PRKCH | 1.44811033 |
| 33 | IRAK1 | 1.44748380 |
| 34 | BMPR1B | 1.34483422 |
| 35 | PTK2B | 1.33151392 |
| 36 | PDGFRA | 1.31025865 |
| 37 | SCYL2 | 1.29262584 |
| 38 | NTRK1 | 1.26668083 |
| 39 | NTRK3 | 1.23539414 |
| 40 | CSNK1G1 | 1.20212215 |
| 41 | BMX | 1.19398754 |
| 42 | AKT3 | 1.18574757 |
| 43 | TAF1 | 1.18223560 |
| 44 | WNK1 | 1.18197183 |
| 45 | FLT3 | 1.16830298 |
| 46 | ADRBK2 | 1.16789694 |
| 47 | MELK | 1.13077590 |
| 48 | TRPM7 | 1.12742119 |
| 49 | BRSK2 | 1.12299729 |
| 50 | IRAK2 | 1.07397359 |
| 51 | GRK1 | 1.06090458 |
| 52 | PTK2 | 1.04007462 |
| 53 | PTK6 | 0.95543464 |
| 54 | CDC42BPA | 0.94497851 |
| 55 | DYRK1B | 0.92695555 |
| 56 | PHKG2 | 0.90694843 |
| 57 | PHKG1 | 0.90694843 |
| 58 | STK38L | 0.89988703 |
| 59 | PAK3 | 0.89252001 |
| 60 | MAP3K9 | 0.86100943 |
| 61 | PRKD2 | 0.85670870 |
| 62 | ZAK | 0.83179184 |
| 63 | MAPK11 | 0.82455359 |
| 64 | FER | 0.81554976 |
| 65 | CASK | 0.80620646 |
| 66 | RET | 0.76556254 |
| 67 | STK39 | 0.69705958 |
| 68 | PDPK1 | 0.69132808 |
| 69 | GSK3A | 0.66782295 |
| 70 | CAMKK1 | 0.66301289 |
| 71 | TAOK1 | 0.64222139 |
| 72 | PRKCQ | 0.63981239 |
| 73 | PRKAA1 | 0.60965585 |
| 74 | PDK1 | 0.60963731 |
| 75 | ALK | 0.60357088 |
| 76 | CSNK1G3 | 0.59101786 |
| 77 | FGR | 0.58876737 |
| 78 | MET | 0.58393623 |
| 79 | MAP3K3 | 0.56538755 |
| 80 | LATS1 | 0.55978606 |
| 81 | PRKG1 | 0.55879833 |
| 82 | LIMK1 | 0.55845211 |
| 83 | SIK1 | 0.55452199 |
| 84 | OXSR1 | 0.55370904 |
| 85 | JAK2 | 0.54523633 |
| 86 | VRK1 | 0.53828888 |
| 87 | RPS6KA2 | 0.53323701 |
| 88 | MAP2K2 | 0.52468491 |
| 89 | EPHB1 | 0.52302784 |
| 90 | FGFR4 | 0.51970163 |
| 91 | MAP3K10 | 0.51493737 |
| 92 | PIK3CA | 0.51455053 |
| 93 | CAMK2D | 0.51040844 |
| 94 | JAK1 | 0.50470061 |
| 95 | PRKCI | 0.49656198 |
| 96 | KSR2 | 0.48884795 |
| 97 | STK3 | 0.47597596 |
| 98 | RPS6KB2 | 0.45345323 |
| 99 | DAPK1 | 0.45214079 |
| 100 | MAPK13 | 0.44721814 |
| 101 | PRKD1 | 0.44666779 |
| 102 | CSNK1G2 | 0.43097666 |
| 103 | SGK494 | 0.42884981 |
| 104 | SGK223 | 0.42884981 |
| 105 | SGK3 | 0.42600705 |
| 106 | BCR | 0.41358319 |
| 107 | MTOR | 0.41280040 |
| 108 | EIF2AK3 | 0.41135886 |
| 109 | ROCK1 | 0.40308170 |
| 110 | EPHA2 | 0.40218589 |
| 111 | PRKCE | 0.40102966 |
| 112 | BMPR2 | 0.36215972 |
| 113 | PDGFRB | 0.36161606 |
| 114 | PRKAA2 | 0.35788326 |
| 115 | SGK2 | 0.35768642 |
| 116 | MAPKAPK3 | 0.34789110 |
| 117 | BRSK1 | 0.33152284 |
| 118 | FGFR3 | 0.32298503 |
| 119 | MUSK | 0.32127483 |
| 120 | IKBKB | 0.32075962 |
| 121 | CAMK2B | 0.30229679 |
| 122 | RPS6KA1 | 0.29923676 |
| 123 | PRKACG | 0.27751259 |
| 124 | NLK | 0.26066131 |
| 125 | CDK5 | 0.25600308 |
| 126 | TNK2 | 0.25272161 |
| 127 | ADRBK1 | 0.24540120 |
| 128 | CAMK1G | 0.24028048 |
| 129 | MAP2K1 | 0.23784766 |
| 130 | CDK12 | 0.23683187 |
| 131 | RPS6KA3 | 0.23504026 |
| 132 | MARK2 | 0.23500141 |
| 133 | PRKACA | 0.22799652 |
| 134 | MAPK14 | 0.20217874 |
| 135 | PRKDC | 0.19306974 |
| 136 | IGF1R | 0.18846882 |
| 137 | TESK1 | 0.17671570 |
| 138 | PRKCA | 0.17487527 |
| 139 | CSNK1A1L | 0.16534366 |
| 140 | CSNK1A1 | 0.15889032 |
| 141 | AKT1 | 0.15802185 |
| 142 | ITK | 0.14477464 |
| 143 | SGK1 | 0.13964346 |
| 144 | ERBB3 | 0.13499112 |
| 145 | GSK3B | 0.13426029 |
| 146 | BRAF | 0.13408050 |
| 147 | RPS6KB1 | 0.12640353 |
| 148 | PINK1 | 0.12520505 |
| 149 | DAPK2 | 0.11957056 |
| 150 | RPS6KL1 | 0.11735672 |
| 151 | RPS6KC1 | 0.11735672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.95349784 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.66464430 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.79669229 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.75108739 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.68580480 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.62184215 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03507503 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00394701 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97593923 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 1.71684191 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71639694 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64570828 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52616225 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52254038 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51461008 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51428052 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.42217862 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.40695417 |
| 19 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.39385915 |
| 20 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.38187984 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36131463 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.34409171 |
| 23 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.33450205 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31154942 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28630002 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.27917017 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22164307 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.21654427 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21523150 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18608808 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18248089 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.17716157 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15463185 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15168657 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13892123 |
| 36 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.13568059 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10986083 |
| 38 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.10278077 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.09205412 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.01972819 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.01889798 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00439304 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98941943 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93293792 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93234519 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92735590 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.90904486 |
| 48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90598329 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89290479 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86682569 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 0.84386897 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83861116 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83834593 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83074709 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82597270 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82498858 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82379763 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.80621516 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80364489 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80033477 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78607356 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76090858 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71893517 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71360127 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70842361 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69908447 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.68129042 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68117596 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67877574 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65909327 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65179234 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 0.65140993 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65036326 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64248373 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63947770 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63231794 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62801411 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62595708 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62570239 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62117313 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.60312664 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.57472419 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57181728 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56026709 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55879557 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55123658 |
| 87 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54265442 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53898739 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53782474 |
| 90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53487367 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52837816 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.52764856 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51721967 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.50884946 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50851332 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50722613 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48502110 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.47970052 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45598719 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45042640 |
| 101 | Nicotine addiction_Homo sapiens_hsa05033 | 0.44477652 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42050231 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41997335 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39478645 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39446824 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37556146 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37296946 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37135516 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.36832629 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.36724401 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36430850 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35949884 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35151656 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.35066705 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34954157 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33437625 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.32428650 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31894287 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.30578996 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30345537 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30234703 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.28965031 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.27693360 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27384339 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26839583 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25009727 |
| 127 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23459237 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23288504 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23258426 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.22186899 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20943985 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.20775780 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.19772573 |
| 134 | Olfactory transduction_Homo sapiens_hsa04740 | 0.16438683 |

